Clinical trial
Study of Smith-Lemli-Opitz Syndrome
NCT00001721 · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), NIH · Completed
Key facts
| NCT number | NCT00001721 |
|---|---|
| Title | Study of Smith-Lemli-Opitz Syndrome |
| Official title | Clinical and Basic Investigations Into Smith-Lemli-Opitz Syndrome |
| Lead sponsor | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Smith-Lemli-Opitz Syndrome |
| Intervention type | Drug |
| Interventions | Cholesterol Suspension, CRH, Cholesterol |
| Enrollment | 130 |
| Start date | Sep 13, 1998 |
| First posted | Nov 4, 1999 |
| Last update posted | Jan 5, 2026 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: